A previous report showed that silencing of CHRM3-AS2 expression inhibited cell viability, colony formation, migration, and invasion and promoted apoptosis effects by targeting miR-370-5p/KLF4 in Glioma [87]. Here, KLF4 is linked to central nervous system cancer.